Advertising and commercially sponsored publications do not influence editorial decisions. Journal of Heart and Lung Research (abbreviated as JHLR) will not endorse any product or service indicative of an advisement or promoted by a sponsor in its own publications. The editorial content will not be bound by commercial or financial interests, or by any specific arrangements with advertisers or sponsors.
Advertisements with potential concerns about damages to JHLR’s brand and inappropriateness to the content on its website will be declined. Advertisements involved products or services exerting detrimental effects on health (e.g., tobacco and alcohol products) will be declined.
Advertisements should made clear identification of the advertiser and the product, service being offered with trademark or signature. Any cheating, misleading or exaggerated contents being further from the truth may not appear in advertisements. Any indecent or offensive contents in either text or artwork may not appear in advertisements, such as any discrimination of individual privacy, race, gender, or religion.
Advertisement will be displayed on the journal website, not the published papers. Advertising should always be separated from content in articles published in JHLR. Advertising regarding specific treatments or drugs is allowed to link to any page of published articles for promotional purposes, which means it is unavailable for readers to find advertising information when reading articles, even when searching relevant keywords.
Correct and rational use without misleading is greatly recommended in these advertisements for specific drugs, which fully comply with the specific countries’ legislation that regulates advertising. Advertisers should offer relevant marketing authorization and summary of product characteristics to JHLR at the time of submitting their advertisement . To be specific, full generic name of each active ingredient should be clearly described in drug advertisements' contents. Identification information of a prescription-only medicine should be made on each page of such advertisement for health professionals’ reference.
Journal editors are entitled to make decisions where current or potential sponsors and advertisers as well as marketing decisions are inapplicable. Search results are based solely on the functionality available through our search software and user-defined criteria (e.g., keyword or topic) rather than special settings from advertisers and sponsors.
The online advertisement will be withdrawn from the journal site at any time as requested by Editor(s)-in-Chief or Publisher. Once additional advertising positions are required beyond JHLR standards, please make a request to editorial office. Any complaints regarding advertisements will be presented in the advertisements page.
Please feel free to contact us by collaborations@exploverpub.com for any further questions or collaborations.
Editor-in-Chief:
Alfredo R. Galassi,
Cardiovascular Medicine Department of ProMISE, University of Palermo, 90133 Palermo PA, Italy
ISSN: 2835-3528 (Online)
Frequency: quarterly
Submission to final decision:
60-90 days
Acceptance to publication: 15 days
Category:
Cardiac & Cardiovascular System
Respiratory System
© 2024 The Author(s). Published by Exploration and Verfication Publishing
